FDA Approves Fourth Denosumab Biosimilar ...Middle East

Medscape - News
FDA Approves Fourth Denosumab Biosimilar
Denosumab-bnht is expected to launch in the US in June 2025 per an agreement with the reference product’s manufacturer, Amgen. Medscape Medical News

Hence then, the article about fda approves fourth denosumab biosimilar was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Fourth Denosumab Biosimilar )

Apple Storegoogle play

Last updated :

Also on site :